Politicians shouldn’t play God with drugs funding
Prioritising one patient group - perhaps because of the power of their advocacy - means another group will lose out, even if their case for funding is much stronger
The process by which new, innovative medicines are made available to patients through the health service is broken. It was broken by the Department of Health’s failure to plan ahead for the pipeline of new, reimbursable drugs, and by political meddling that has undermined the credibility of what should be an evidence-based, clinically validated process of priority-setting solely according to health benefit.
Superficially, this might seem like a technical squabble among civil servants and...
Subscribe from just 1€
Choose the subscription that is right for you
For the first month
€19.99 Monthly ThereafterSubscribe today
For the first year
€199.99 annually thereafterSubscribe today
For the first 90 days
€55.00 quarterly ThereafterSubscribe today
These offers are not available for current subscribers. Offers and pricing are subject to change without notice.
Terms & Conditions Apply